P1156: MAGNIFY PHASE 3B STUDY OF LENALIDOMIDE + RITUXIMAB (R2) FOLLOWED BY MAINTENANCE IN RELAPSED/REFRACTORY INDOLENT NON-HODGKIN LYMPHOMA: COMPLETE INDUCTION PHASE ANALYSIS
HemaSphere | June 23, 2022 | Volume: 6 | Issue: No issue available | Pages: 1043-1044
10.1097/01.hs9.0000847492.88194.df